Phlox Therapeutics raised €1.9M in a funding round in Nov 2024. The company is based in Naarden, Netherlands. Investors in the round: Amsterdam UMC Venture Holding, FIRST Fund, ROM Utrecht Region and 2 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €1.9M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
